Back to Anacor Homepage Developing Drug Candidates Through Boron Chemistry
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
Investors overview.gif
Investor Relations Contact:
ir@anacor.com
Phone: 650-543-7575

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Anacor Pharmaceuticals, Inc.'s financial performance into perspective.

View all »Recent Releases

Oct 9, 2014
Anacor Pharmaceuticals, Inc. Announces Pricing of Offering of $75 Million of 2.00% Convertible Senior Notes Due 2021

Oct 8, 2014
Anacor Pharmaceuticals, Inc. Announces Proposed Offering of $70 Million of Convertible Senior Notes Due 2021

View all »Events & Presentations

Sep 9, 2014 at 3:30 PM ET
Morgan Stanley Global Healthcare Conference

Aug 14, 2014 at 3:30 PM ET
Canaccord Genuity 34th Annual Growth Conference

Aug 13, 2014 at 8:35 AM ET
Wedbush Life Sciences Management Access Conference

Receive Email Alerts

Sign up to receive e-mail alerts whenever Anacor posts new information to the site.



(ANAC): NASDAQ
Price: 28.43 Change: +0.77
High: 28.73 %Change: 2.784%
Low: 27.75 Volume: 180,800